GARY STETZ

Profile

First Name

: GARY

Middle Name

:

Last Name

: STETZ

Related Companies
Titles
Company Name
Related People
DIRECTOR
BCB BANCORP INC
ROBERT BALLANCE, JUDITH BIELAN, JUDITH Q. BIELAN, JUDITY Q. BIELAN, RYAN BLAKE, JOHN J. BROGAN, JOSEPH J. BROGAN, JOHN J. BROGAN, ESQ., JAWAD CHAUDHRY, JAMES COLLINS, JAMES E COLLINS, JAMES E. COLLINS, THOMAS COUGHLIN, VINCENT DIDOMENICO, JR., KENNETH G. EMERSON, TARA L. FRENCH, DAVID GARCIA, FRANK GRECO, MARK HOGAN, MARK D. HOGAN, ROBERT HUGHES, JOSEPH JAVITZ, THOMAS P. KEATING, MICHAEL LESLER, JOSEPH LYGA, JOSEPH E. LYGA, DONALD MINDIAK, ALEXANDER PASIECHNIK, AUGUST PELLEGRINI, AUGUST PELLEGRINI, JR., JOHN PULOMENA, JAMES RIZZO, JAMES G. RIZZO, SPENCER ROBBINS, SPENCER B. ROBBINS, AMER SALEEM, MICHAEL A. SHRINER, SANDRA SIEVEWRIGHT, SANDRA L. SIEVEWRIGHT, GARY S. STETZ, RAYMOND J. VANARIA, KENNETH D. WALTER, MICHAEL J. WIDMER
DIRECTOR
THARIMMUNE, INC.
KELLY ANDERSON, SIREESH APPAJOSYULA, JACOB ASBURY, LYNNE A BUI, LYNNE A/ BUI, THOMAS HESS, CLAY KAHLER, JAMES GORDON LIDDY, VINCENT LOPRIORE, LEONARD MAZUR, RANDY MILBY, SANAM PARIKH, ANGELA RADKOWSKI, JILL SOMMERS, MARK TOOMEY, MARK WENDLAND, WILLIAM WILEY
DIRECTOR
CANTON STRATEGIC HOLDINGS, INC.
KELLY ANDERSON, SIREESH APPAJOSYULA, JACOB ASBURY, LYNNE A BUI, LYNNE A/ BUI, THOMAS HESS, CLAY KAHLER, JAMES GORDON LIDDY, VINCENT LOPRIORE, LEONARD MAZUR, RANDY MILBY, SANAM PARIKH, ANGELA RADKOWSKI, JILL SOMMERS, MARK TOOMEY, MARK WENDLAND, WILLIAM WILEY
EXECUTIVE OFFICER, DIRECTOR
HEPION PHARMACEUTICALS, INC.
THOMAS ADAMS, SIREESH APPAJOSYULA, TIMOTHY BLOCK, JOHN BRANCACCIO, JOHN P. BRANCACCIO, JOHN CAVAN, BERNARD F. DENOYER, ROBERT FOSTER, TODD HOBBS, BILL HORNUNG, GARY JACOB, GARY S. JACOB, GARY S. JACOBS, KAOUTHAR LBIATI, ARNOLD LIPPA, CHASE LOPRIORE, VINCENT LOPRIORE, CHRISTOPHER MCGUIGAN, MICHAEL PURCELL, ANAND REDDI, JAMES SAPIRSTEIN, PETRUS WIJNGAARD
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-22
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2026-04-21 
2026-04-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-25 
2026-04-15
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-07-23 
2025-07-07
D
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2025-06-13 
2013-11-13
D
Link
COMMERCIAL BANKING 
SAVINGS INSTITUTION, FEDERALLY CHARTERED [6035] 
$25,000,001 - $100,000,000 
Equity 
2013-10-31